Fulton will be present at the next Vitafoods Europe 2021 at the Palexpo in Geneva, Switzerland , from October 5th to 7th. You can find...
August 30, 2021
• News
LACTOFERRIN FULTON IN UAE
Fulton, with PHARMALINK, have received registration certificate for the products LACTIFOL (B9Ferrina) and FERIKKTO (Fe2Ferrina) in United Arab Emirates (UAE).
July 15, 2021
• News
LACTOFERRIN FULTON IN UKRAINE
Fulton, with VORWARTS PHARMA, have received registration certificate for the products BISFERRO (B9Ferrina) and PORTOFERRO (Fe2Ferrina) in Ukraine.
June 17, 2021
• News
New authorization IMP
Fulton receives from AIFA a new authorization for the Investigational Medicinal Product (IMP) production of the suppositories pharmaceutical form.
January 22, 2021
• News
PATENT
ITALY - Fulton Medicinali Invention patent Application No. 102019000000897 (formerly PHF sa) for the prolonged release formulation with gastric permanence based on Nitrofurantoin With this...
January 14, 2021
• News
NOTICE OF PUBLICATION OF APPLICATION
U.S.A. Fulton Medicinali SpA Patent Deposit N ° US2021/0007979 A1 for sublingual tablet comprising Sidenafil Citrate. With this important result, the italian company expands the...